Close

Gilead Sciences (GILD) Numbers Raised after Solid Qtr - Needham & Company

Go back to Gilead Sciences (GILD) Numbers Raised after Solid Qtr - Needham & Company

Baird Downgrades Gilead Sciences (GILD) to Neutral

July 26, 2013 10:03 AM EDT

Baird downgraded Gilead Sciences (NASDAQ: GILD) from Outperform to Neutral.

For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.

Shares of Gilead Sciences closed at $60.86 yesterday, with a 52 week range of $39.21-$79.37.... More

Atlantic Equities Upgrades Gilead Sciences (GILD) to Overweight

July 26, 2013 7:59 AM EDT

Atlantic Equities upgraded Gilead Sciences (NASDAQ: GILD) from Neutral to Overweight with a price target of $73.00 (from $53.00).

For an analyst ratings summary and ratings history on Gilead Sciences click here. For more... More

Gilead Sciences, Inc. (GILD) Reports In-Line Q2 EPS

July 25, 2013 4:07 PM EDT

Gilead Sciences, Inc. (NASDAQ: GILD) reported Q2 EPS of $0.50, in-line with the analyst estimate of $0.50. Revenue for the quarter came in at $2.77 billion versus the consensus estimate of $2.66 billion.

For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.... More